FindTrial
Sign In

Effectiveness of Galantamine on the care burden of family caregivers of patients with Alzheimer's disease

Effectiveness of Galantamine on the care burden of family caregivers of patients with Alzheimer's disease - Effectiveness of Galantamine on the care burden in Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009934
Enrollment
200
Registered
2013-02-05
Start date
2013-02-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

Galantamine treatment

Sponsors

Juntendo University School of Medicine, Department of Neurology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The subjects met the criteria of Alzheimer's disease in the Nationnal Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders association (NINCDS-ADRDA) 2. The subjects score more than 15 and less than 27 in the MMSE. 3. outpatients

Exclusion criteria

Exclusion criteria: 1. Alcoholics 2. patients with epilepsy 3.

Design outcomes

Primary

MeasureTime frame
The Zarit Burden Interview—

Secondary

MeasureTime frame
Neuropsychiatric Inventory—

Countries

Japan

Contacts

Public ContactYumiko Motoi

Juntendo University School of Medicine Department of Neurology

motoi@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026